secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2022-11-07T23:59:59+00:00
Accession:  0000883984-22-000044
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical Q3 2022 revenue $597.9M; GAAP loss $(0.55)/share; adj EPS $1.75
---------------------------------------------------------------------------

- Revenue $597.9M vs $336.1M YoY (+78%); GAAP net loss $(13.2)M ($(0.55)/diluted share).
- Adjusted diluted EPS $1.75 vs $2.07 YoY; adjusted EBITDA $92.6M vs $71.9M.
- GAAP gross margin 31% vs 38% YoY; gross profit $186.4M vs $127.8M.
- Reaffirmed fiscal year 2022 guidance; no specific guidance numbers provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000088398422000044/0000883984-22-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000088398422000044/icui-20221107.htm
  HTML page:      https://secwatch.observer/filing/0000883984-22-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer